Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 332

Results For "STI"

7066 News Found

Metropolis Healthcare posts Q1 FY25 at Rs. 38.1 Cr
News | August 12, 2024

Metropolis Healthcare posts Q1 FY25 at Rs. 38.1 Cr

Revenue from operations stood at Rs. 313.4 crore during Q1 FY25


Merck's aarogya health program positively impacts communities in Patalganga
Healthcare | August 11, 2024

Merck's aarogya health program positively impacts communities in Patalganga

Aarogya program aims to improve the overall health outcomes for the community by offering comprehensive health screenings, diagnostic support, and increased health awareness


Allergan Aesthetics drives India’s potential in the global aesthetic market
News | August 11, 2024

Allergan Aesthetics drives India’s potential in the global aesthetic market

The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020


Zydus Lifesciences Q1 FY25 revenue up 21% YoY to reach Rs. 6,207.5 Cr
News | August 11, 2024

Zydus Lifesciences Q1 FY25 revenue up 21% YoY to reach Rs. 6,207.5 Cr

Research & Development (R&D) investments for the quarter stood at Rs. 392.5 crore which is 6.3% of its revenues


HealthCare Global Enterprises posts Q1 FY25 PAT higher at Rs. 12.1 Cr
News | August 11, 2024

HealthCare Global Enterprises posts Q1 FY25 PAT higher at Rs. 12.1 Cr

Our centers are performing as expected or even better


Jan Aushadhi Kendras have sold Rs. 5,600 Cr medicines over last 10 years
Policy | August 10, 2024

Jan Aushadhi Kendras have sold Rs. 5,600 Cr medicines over last 10 years

The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024


Atul Bioscience received EIR from USFDA for Ambernath facility
Drug Approval | August 09, 2024

Atul Bioscience received EIR from USFDA for Ambernath facility

The EIR was issued post the last inspection of the facility conducted from May 6-10, 2024 which concluded with zero FDA 483 observations


JB Pharma records Q1 FY25 PAT higher by 25% to Rs. 177 Cr
News | August 08, 2024

JB Pharma records Q1 FY25 PAT higher by 25% to Rs. 177 Cr

Expect the international business including CDMO business to pick-up in the second half of the financial year


Apollo Clinic launches nationwide vaccination campaign to tackle monsoon illnesses
Healthcare | August 08, 2024

Apollo Clinic launches nationwide vaccination campaign to tackle monsoon illnesses

Organization to provide vaccinations & treatments for several monsoon related diseases and illnesses across all 102 clinics